About ABACUS
Cooperative efforts of many dedicated individuals at the University of Alberta and
Capital Health resulted in the creation of the Alberta Cardiovascular and Stroke Research Centre (ABACUS).
Directed by Dr. Gary Lopaschuk and administered by Ms Donna Daniec, this $18 million,
translational, research centre is funded by several federal and provincial agencies, including
the Canada Foundation for Innovation.
Investigators
ABACUS will serve over 100 investigators and their trainees in Edmonton and Calgary. The lead investigators in
ABACUS are internationally recognized leaders in their research fields,
ranging from informatics to cardiac and neuro intervention. They hold a variety
of Canada Research Chairs, direct research groups, and function as medical and
scientific leaders.
Mission
The mission of this multidisciplinary faculty is to perform outstanding research
aimed at the prevention, detection, and cure of cardiovascular diseases (CVD),
including stroke. The research will be conducted at levels ranging from
Molecules to Populations. The focused research mission provides a home for
investigator-initiated research, and will also enhance patient care and
contribute to the education of scientists and cardiovascular healthcare
professionals.
Location
ABACUS was designed by HIP Architects (Allan Partridge) and built by Delnor
Construction in level 0 of the Mazankowski Alberta Heart Institute. ABACUS will occupy 1800m2 on a research
floor shared with a CFI-funded in University of Alberta In Vivo NMR Research Centre. Located in close
proximity to a tertiary care Emergency Department and the Mazankowski Alberta Heart Institute,
ABACUS has unparalleled capacity to support research on subjects with acute and
severe cardiovascular illnesses.
Position
ABACUS is a 'research hospital within a hospital' that will enable researchers
to quickly apply breakthrough therapies and revolutionary biomedical devices to
patients participating in studies or clinical trials. This innovative centre
will not only help patients, but also helps Canadian scientists to perform
groundbreaking research and compete on the international stage. ABACUS is
strategically aligned and seamlessly integrated with the Mazankowski Alberta Heart
Institute, the University of Alberta Faculty of Medicine & Dentistry and
Alberta Health Services.
Focus
ABACUS builds on Alberta's existing strengths in randomized trials in the areas
of acute ischemic cardiac disease and congestive heart failure, stroke
research, vascular biology, informatics, and imaging. ABACUS will focus on the
following themes:
- Myocardial Ischemia-Acute Coronary Syndromes
- Revascularization and Neuroprotection in Stroke Endothelial Function in health
and disease
- CVD Outcomes
- Health Delivery and Technology Assessment
- Cardioprotection
- Diagnostic and therapeutic modalities for Pulmonary Hypertension and Congenital
Heart Disease
|
